You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 46, 11 June 2004
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 45, 23 April 2004), as amended, are a true and accurate record of that previous meeting.
CMEC notes the literature review prepared by the TGA on the safety of 'sulfites' in medicines and considers that there is not sufficient evidence to determine a level of exposure to 'sulfites' in medicines which is without risk to sensitive individuals. The CMEC reaffirms that all medicines containing 'sulfites' should be labelled in accordance with the current requirements of Therapeutic Goods Order No 69.
|Complementary Medicines Evaluation Committee meeting 46 (pdf)||55KB|